Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Fabscout Entertainment, Inc to request your refund or repair — edit it as you like.
Subject: Recall D-1169-2014 — Fabscout Entertainment, Inc Fabscout Entertainment, Inc recalls Clalis capsules, 50 mg, 6 -count bo Hello, I own a Fabscout Entertainment, Inc recalls Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language) that is covered by recall D-1169-2014 from Fabscout Entertainment, Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
